Landmark trial
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial
Murthy V, Maitre P, Bhatia J, et al.
DoseLab summary
Late toxicity and quality-of-life results from the randomized POP-RT trial of prostate-only versus whole-pelvic radiotherapy. Citation as given in the eviQ reference list.
Why this is useful
Late toxicity report of the POP-RT trial; the source of the 25-fraction rectum, bladder, bowel bag and large bowel limits.
Reference details
- Title
- Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial
- Authors / organization
- Murthy V, Maitre P, Bhatia J, et al.
- Publication / protocol
- Radiother Oncol. 2020;145:71–80
- Version
- Pending verification
- Year
- 2020
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, Pelvic nodes, Landmark trial, Toxicity
- Fractionation context
- 25 fractions (prostate-only vs whole pelvis)
- Last reviewed by DoseLab
- Pending verification